BCAL launches national registry to track real-world impact of BREASTESTplus

BCAL Diagnostics (ASX:BDX) has taken a major step toward strengthening clinical confidence in its flagship breast cancer diagnostic, announcing national ethics approval for a large-scale registry that will track outcomes for up to 24,000 Australian women. …